You are here

IGF::OT::IGF -- Biomarkers for Alcohol and ALD

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N44AA140007
Agency Tracking Number: N44AA140007
Amount: $625,360.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NIAAA
Solicitation Number: N/A
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
675 Arapeen Drive, Suite 302
Salt Lake City, UT 84108-1228
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (801) 588-0455
Business Contact
Phone: (801) 588-0455
Research Institution

This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Business Innovation Research (SBIR) contract topic on Biomarkers for Alcohol-induced Disorders. The goals of this contract are to advance the usefulness of phosphatidylethanol (PEth), an alcohol metabolite, as a clinical biomarker of alcohol consumption, by designing an antibody-based method of quantitation that ischeaper and more accessible to small hospitals and clinics than currently used chromatographic/ spectrophotometric methods. This contract is a continuation of a Phase II SBIR contract with Echelon Biosciences, Inc. It was awarded under SBIR solicitation PHS-2008-1, Topic 031. This effort is deemed to be non-severable. PUBLIC HEALTH RELEVANCE

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government